Showing results (1501-1510 of 9,902) with videos related to

Sort By:
Pageof 991
Bone Marrow Transplantation|February 23, 2002
Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantationM C Dignani, A Mykietiuk, M Michelet, et al.
Bone Marrow Transplantation|February 23, 2002
Successful allogeneic bone marrow transplantation from an HBV-positive donor into an HBV-positive recipient using lamivudineS Hashino, M Takahata, A Nozawa, et al.
Bone Marrow Transplantation|July 1, 1991
Some but not all benefits of intravenous immunoglobulin therapy after marrow transplantation appear to correlate with IgG trough levelsM Cottler-Fox, M Lynch, L W Pickle, et al.
Bone Marrow Transplantation|July 1, 1991
Purging of small cell lung cancer cells from bone marrow using immunomagnetic beads and a flow-through deviceE D Ball, F J Powers, J J Vredenburgh, et al.
Bone Marrow Transplantation|April 11, 2006
Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individualM Sundin, C Orvell, I Rasmusson, et al.
Bone Marrow Transplantation|January 23, 1999
A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignanciesA C Vigorito, W M Azevedo, J F Marques, et al.
Bone Marrow Transplantation|January 23, 1999
Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies: a pilot studyD Blaise, E Jourdan, M Michallet, et al.
Bone Marrow Transplantation|January 23, 1999
Correction of neutropenia and hypogammaglobulinemia in X-linked hyper-IgM syndrome by allogeneic bone marrow transplantationP R Scholl, M R O'Gorman, L M Pachman, et al.
Bone Marrow Transplantation|December 16, 1998
Hematopoietic stem cell transplantation for infantile osteopetrosisM Eapen, S M Davies, N K Ramsay, et al.
Bone Marrow Transplantation|December 16, 1998
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignanciesP V O'Donnell, R J Jones, G B Vogelsang, et al.
Pageof 991